Endo International | ENDP - Ebitda



Ebitda Veränderung Datum
AbbVie USD 3.69B 1.68B 2026-03
Amarin USD 12.54M 28.57M 2025-06
ANI Pharmaceuticals USD 71.6M 6.69M 2026-06
Bristol-Myers Squibb USD 4.24B 1.37B 2026-03
Coherus Biosciences USD -43.33M 4.7M 2025-09
Eli Lilly USD 10.29B 1.86B 2026-03
Heron Therapeutics USD -3.88M 5.63M 2024-09
Hikma Pharmaceutical USD 369M 84M 2024-12
Ligand Pharmaceuticals USD -14.3M 81.08M 2026-03
Merck USD -1.54B 7.84B 2026-03
Novartis USD 6.48B 1.19B 2026-06
Pacira USD 48.67M 8.43M 2026-06
Perrigo USD 141.6M 1.34B 2026-03
Pfizer USD 6.01B 18M 2026-06
Phibro Animal Health USD 68.1M 6.2M 2025-12
Supernus Pharmaceuticals USD 31.6M 2.37M 2026-06
Takeda JPY 364.46B 214.21B 2026-06
Teva Pharmaceutical Industries USD 474M 581M 2026-06
Xeris Pharmaceuticals USD 12.33M 12.76M 2026-03
Zoetis USD 939M 0 2026-03